Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries

BACKGROUND: We explored the outcome of convalescent plasma (CP) treatment in patients with moderate and severe coronavirus disease 2019 (COVID-19) and investigated variables for the design of further trials in Indonesia. METHODS: Hospitalised patients with moderate (n = 5) and severe (n = 5) COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Rejeki, Marliana S., Sarnadi, Nana, Wihastuti, Retno, Fazharyasti, Vininta, Samin, Wisvici Y., Yudhaputri, Frilasita A., Johar, Edison, Nurainy, Neni, Bachtiar, Novilia S., Muljono, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175127/
https://www.ncbi.nlm.nih.gov/pubmed/34104878
http://dx.doi.org/10.1016/j.eclinm.2021.100931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175127/
https://www.ncbi.nlm.nih.gov/pubmed/34104878
http://dx.doi.org/10.1016/j.eclinm.2021.100931

Ejemplares similares